key: cord-0010556-jf1t5jhf
authors: Giacomelli, Andrea; Pezzati, Laura; Conti, Federico; Bernacchia, Dario; Siano, Matteo; Oreni, Letizia; Rusconi, Stefano; Gervasoni, Cristina; Ridolfo, Anna Lisa; Rizzardini, Giuliano; Antinori, Spinello; Galli, Massimo
title: Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
date: 2020-03-26
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa330
sha: 2cd6ee7dacffd0fcc7a800572c14761d18f5cbbf
doc_id: 10556
cord_uid: jf1t5jhf

nan

To the Editor-We read with interest the article by Wang et al [1] describing the clinical features of 69 patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China. The authors provide a detailed description of major signs and symptoms of overt disease [2, 3] , but fail to give an account of minor symptoms that may be present at earlier stages of the infection.

After some patients admitted for coronavirus disease 2019 (COVID-19) at the Infectious Disease Department of L. Sacco Hospital in Milan, Italy, complained of olfactory and taste disorders (OTDs), we performed a cross-sectional survey of the prevalence of these alterations in the context of SARS-CoV-2 infection. On 19 March 2020, a simple questionnaire including questions about the presence or absence of OTDs, their type and time of onset respective to hospitalization were submitted through verbal interview to all SARS-CoV-2positive hospitalized patients who were able to give informed consent. Of 88 hospitalized patients, 59 were able to be interviewed (29 were nonrespondents, of whom 4 had dementia, 2 had a linguistic barrier, and 23 were on noninvasive ventilation) ( Table 1) . Of these, 20 (33.9%) reported at least 1 taste or olfactory disorder and 11 (18.6%) both. Twelve patients (20.3%) presented the symptoms before the hospital admission, whereas 8 (13.5%) experienced the symptoms during the hospital stay. Taste alterations were more frequently (91%) before hospitalization, whereas after hospitalization taste and olfactory alteration appeared with equal frequency. Females reported OTDs more frequently than males Olfactory and taste disorders are well known to be related with a wide range of viral infections [4, 5] . SARS-CoV has demonstrated in a mice model a transneural penetration through the olfactory bulb [6] . Moreover, angiotensinconverting enzyme 2 receptor, which is used by SARS-CoV-2 to bind and penetrate into the cell, is widely expressed on the epithelial cells of the mucosa of the oral cavity [7] . These findings could explain the underlying pathogenetic mechanism of taste and olfactory disorders in SARS-CoV-2 infection.

Due to limitations related to the diffusivity of the disease and emergency contingencies, it was impossible to perform a more structured questionnaire associated with validated tests (ie, Pennsylvania smell identification test) [8] . However, our survey shows that OTDs are fairly frequent in patients with SARS-CoV-2 infection and may precede the onset of full-blown clinical disease. In a pandemic context, further investigations on nonhospitalized infected patients are required to ascertain if these symptoms, albeit unspecific, may represent a clinical screening tool to orientate testing of pauci-symptomatic individuals. 

Clinical features of 69 cases with coronavirus disease

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China

Smell and taste disorders

The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Development of the University of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function